Woodline Partners’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,050,994
Closed -$7.29M 958
2024
Q3
$7.29M Buy
1,050,994
+1,006,339
+2,254% +$7.9M 0.06% 341
2024
Q2
$348K Buy
+44,655
New +$331K ﹤0.01% 513
2023
Q3
Sell
-675,728
Closed -$3.73M 645
2023
Q2
$3.73M Buy
675,728
+61,278
+10% +$330K 0.04% 338
2023
Q1
$3.84M Sell
614,450
-906,762
-60% -$5.06M 0.05% 332
2022
Q4
$7.09M Buy
+1,521,212
New +$7.49M 0.09% 264
2022
Q1
Sell
-52,966
Closed -$1.73M 763
2021
Q4
$1.73M Sell
52,966
-24,480
-32% -$985K 0.02% 437
2021
Q3
$3.18M Buy
77,446
+44,939
+138% +$1.63M 0.05% 328
2021
Q2
$1.17M Buy
+32,507
New +$1.2M 0.02% 421
2021
Q1
Sell
-114,520
Closed -$4.62M 446
2020
Q4
$4.62M Buy
114,520
+52,020
+83% +$2.39M 0.12% 160
2020
Q3
$3.48M Buy
+62,500
New +$3.31M 0.11% 148

Other funds holding GDRX

Woodline Partners's GDRX Position: Q4 2024 in Review

Woodline Partners sold out of GoodRx Holdings (GDRX) in Q4 2024, closing a stake of 1,050,994 shares — an estimated $7.29M sold.

Woodline Partners first reported a position in GDRX in Q3 2020 and held it in 10 quarters. The position peaked at $7.29M in Q3 2024. 170 funds tracked by Wall St. Rank hold GDRX as of Q4 2024.

  • Woodline Partners reported no remaining GoodRx Holdings position as of Q4 2024 after selling out during the quarter.
  • Woodline Partners sold 1,050,994 GoodRx Holdings shares in Q4 2024, an estimated $7.29M.
  • Woodline Partners first reported a position in GoodRx Holdings in Q3 2020 and held it in 10 quarters.
  • Woodline Partners's GoodRx Holdings position peaked at $7.29M in Q3 2024.
  • 170 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2024.

Based on Woodline Partners's 13F filing for Q4 2024, filed 14 Feb 2025.